The historical rank and industry rank for Tekla World Healthcare Fund's ROE % or its related term are showing as below:
THW'
s ROE % Range Over the Past 10 Years
Min: -12.32 Med: 8.35 Max: 19.9
Current: 17.87
During the past 9 years, Tekla World Healthcare Fund's highest ROE % was 19.90%. The lowest was -12.32%. And the median was 8.35%.
THW's ROE % is ranked better than 78.94% of 1610
companies
in the Asset Management industry
Industry Median: 6.62
vs THW: 17.87
Tekla World Healthcare Fund (NYSE:THW) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, Tekla World Healthcare Fund's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tekla World Healthcare Fund ROE % vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Tekla World Healthcare Fund's ROE % distribution charts can be found below:
* The bar in red indicates where Tekla World Healthcare Fund's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Tekla World Healthcare Fund (THW) has a ROE % of -1.66% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Tekla World Healthcare Fund and its competitors. According to the industry distribution chart, Tekla World Healthcare Fund ranks #339 out of 1610 companies in the Asset Management industry, placing it in the top 21.1%.
Is Tekla World Healthcare Fund's ROE % too high?
Tekla World Healthcare Fund's current ROE % is -1.66%. Based on the distribution chart, Tekla World Healthcare Fund ranks #339 out of 1610 companies in the Asset Management industry, which is in the top quartile — a strong position relative to peers. Overall, Tekla World Healthcare Fund has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tekla World Healthcare Fund's ROE % compare to MSIF and IQI?
According to the Asset Management industry distribution chart, Tekla World Healthcare Fund ranks #339 out of 1610 companies for ROE %. This places Tekla World Healthcare Fund in the top 21% of its industry — outperforming the majority of peers. The industry median ROE % is 6.62. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Asset Management company?
The median ROE % among Asset Management companies is 6.62, based on 1,610 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Tekla World Healthcare Fund and its competitors. For the Asset Management industry, the median ROE % is 6.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tekla World Healthcare Fund's current ROE % is -1.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tekla World Healthcare Fund stock overvalued right now?
Based on GuruFocus' analysis, Tekla World Healthcare Fund (THW) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.36, compared to a current price of $13.49 — trading 30.3% below its estimated fair value. The current ROE % is -1.66%. Tekla World Healthcare Fund's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Tekla World Healthcare Fund (THW), the current ROE % is -1.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tekla World Healthcare Fund (THW) Overvalued in 2026?
Based on GuruFocus' analysis, Tekla World Healthcare Fund stock appears to be undervalued.
The current stock price of $13.49 is trading 30.3% below its estimated GF Value™ of $19.36.
GuruFocus considers Tekla World Healthcare Fund to be Significantly Undervalued.
Key valuation signals for THW:
ROE %: -1.66%
GF Value™: $19.36 vs. price of $13.49 (30.3% below fair value)
No single metric tells the full story. See the THW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.
57GF Score
Get the complete analysis for THW
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
THW has been successfully added to your 
